Title Inhibition of PI 3 K promotes dilation of human small airways in a rho kinase-dependent manner

[1]  Joanna L. Sharman,et al.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands , 2015, Nucleic Acids Res..

[2]  Christopher Southan,et al.  The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors , 2015, British journal of pharmacology.

[3]  Christopher Southan,et al.  The Concise Guide to PHARMACOLOGY 2015/16: Enzymes , 2015, British journal of pharmacology.

[4]  A. Litonjua,et al.  Vitamin D Modulates Expression of the Airway Smooth Muscle Transcriptome in Fatal Asthma , 2015, PloS one.

[5]  Paul A Insel,et al.  Experimental design and analysis and their reporting: new guidance for publication in BJP , 2015, British journal of pharmacology.

[6]  S. Erzurum,et al.  Defective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe Asthma , 2015, PloS one.

[7]  S. Wenzel,et al.  IL-13 desensitizes β2-adrenergic receptors in human airway epithelial cells through a 15-lipoxygenase/G protein receptor kinase 2 mechanism. , 2015, The Journal of allergy and clinical immunology.

[8]  Zhihui Xie,et al.  A fungal protease allergen provokes airway hyperresponsiveness in asthma , 2015, Nature Communications.

[9]  G. Donovan,et al.  Force maintenance and myosin filament assembly regulated by Rho-kinase in airway smooth muscle. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[10]  Dino Di Carlo,et al.  Metallization and Biopatterning on Ultra-Flexible Substrates via Dextran Sacrificial Layers , 2014, PloS one.

[11]  S. Liggett,et al.  Bitter taste receptor function in asthmatic and nonasthmatic human airway smooth muscle cells. , 2014, American journal of respiratory cell and molecular biology.

[12]  Bart Hilvering,et al.  Clinical utility of asthma biomarkers: from bench to bedside , 2013, Biologics : targets & therapy.

[13]  R. Panettieri,et al.  Regulation of CD38 expression in human airway smooth muscle cells: role of class I phosphatidylinositol 3 kinases. , 2012, American journal of respiratory cell and molecular biology.

[14]  T. Casale,et al.  Targeting Phosphoinositide 3-Kinase γ in Airway Smooth Muscle Cells to Suppress Interleukin-13-Induced Mouse Airway Hyperresponsiveness , 2012, Journal of Pharmacology and Experimental Therapeutics.

[15]  P. Paré,et al.  Mechanical properties of asthmatic airway smooth muscle , 2011, European Respiratory Journal.

[16]  P. Cooper,et al.  Formoterol and salmeterol induce a similar degree of β2‐adrenoceptor tolerance in human small airways but via different mechanisms , 2011, British journal of pharmacology.

[17]  S. Liggett,et al.  Beta2-Agonist Induced Camp Is Decreased In Asthmatic Airway Smooth Muscle Due To Increased PDE4D , 2011, ATS 2011.

[18]  R. Ulrich,et al.  CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. , 2011, Blood.

[19]  T. Casale,et al.  Phosphoinositide 3-Kinase γ Regulates Airway Smooth Muscle Contraction by Modulating Calcium Oscillations , 2010, Journal of Pharmacology and Experimental Therapeutics.

[20]  Yan Bai,et al.  A mathematical analysis of agonist- and KCl-induced Ca(2+) oscillations in mouse airway smooth muscle cells. , 2010, Biophysical journal.

[21]  C. Brightling,et al.  Human Airway Smooth Muscle Cells from Asthmatic Individuals Have CXCL8 Hypersecretion Due to Increased NF-κB p65, C/EBPβ, and RNA Polymerase II Binding to the CXCL8 Promoter1 , 2009, The Journal of Immunology.

[22]  P. Cooper,et al.  TLR3 activation stimulates cytokine secretion without altering agonist-induced human small airway contraction or relaxation. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[23]  Takehiko Sasaki,et al.  Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice. , 2009, The Journal of allergy and clinical immunology.

[24]  P. Cooper,et al.  Steroids completely reverse albuterol-induced beta(2)-adrenergic receptor tolerance in human small airways. , 2008, The Journal of allergy and clinical immunology.

[25]  M. Watson,et al.  Interleukin 13 Increases Contractility of Murine Tracheal Smooth Muscle by a Phosphoinositide 3-kinase p110δ-Dependent Mechanism , 2008, Molecular Pharmacology.

[26]  R. Léguillette,et al.  Molecular mechanics of smooth muscle contractile proteins in airway hyperresponsiveness and asthma. , 2008, Proceedings of the American Thoracic Society.

[27]  C. Rommel,et al.  Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo. , 2008, Journal of immunology.

[28]  R. Townley.  Interleukin 13 and the beta-adrenergic blockade theory of asthma revisited 40 years later. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[29]  N. Sugimoto,et al.  Essential Role for Class II Phosphoinositide 3-kinase α-Isoform in Ca2+-Induced, Rho- and Rho Kinase-Dependent Regulation of Myosin Phosphatase and Contraction in Isolated Vascular Smooth Muscle Cells , 2007, Molecular Pharmacology.

[30]  K. Okkenhaug,et al.  Role of the phosphoinositide 3‐kinase p110δ in generation of type 2 cytokine responses and allergic airway inflammation , 2007, European journal of immunology.

[31]  Peter Natesan Pushparaj,et al.  Inhibition of Phosphoinositide 3 Kinase by Masoprocol Ameliorates IgE-mediated Anaphylaxis in vivo and ex vivo , 2007, Journal of Allergy and Clinical Immunology.

[32]  N. Sugimoto,et al.  Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. , 2006, The Biochemical journal.

[33]  Yong Chul Lee,et al.  Inhibition of phosphoinositide 3‐kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  Stephen J Hill,et al.  Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells. , 2005, The Journal of pharmacology and experimental therapeutics.

[35]  M. Bihl,et al.  Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. , 2004, The New England journal of medicine.

[36]  E. Smolock,et al.  Phosphatidylinositol 3-kinase modulates vascular smooth muscle contraction by calcium and myosin light chain phosphorylation-independent and -dependent pathways. , 2004, American journal of physiology. Heart and circulatory physiology.

[37]  C. Vlahos,et al.  Anti-inflammatory effects of LY294002, a PI3K inhibitor, in a mouse model of asthma , 2004 .

[38]  Maree H. Poniris,et al.  PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[39]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[40]  M. Laviolette,et al.  Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[41]  M. Grunstein,et al.  IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[42]  J. Kinet,et al.  Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. , 2001, American journal of respiratory and critical care medicine.

[43]  S. Narumiya,et al.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. , 2000, Molecular pharmacology.

[44]  D. Hartshorne,et al.  Inhibition of Rho‐associated kinase blocks agonist‐induced Ca2+ sensitization of myosin phosphorylation and force in guinea‐pig ileum , 2000, The Journal of physiology.

[45]  E. Silverman,et al.  Heterogeneity of therapeutic responses in asthma. , 2000, British medical bulletin.

[46]  R. Pauwels,et al.  Onset and duration of action of single doses of formoterol inhaled via Turbuhaler. , 1998, Respiratory medicine.

[47]  P. Barnes,et al.  Beta-adrenergic receptors and their regulation. , 1995, American journal of respiratory and critical care medicine.

[48]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[49]  S. Hill,et al.  Salmeterol, a long‐acting β2‐adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line , 1993, British journal of pharmacology.

[50]  A. Zwinderman,et al.  Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. , 1992, The New England journal of medicine.

[51]  R. Panettieri,et al.  A human airway smooth muscle cell line that retains physiological responsiveness. , 1989, The American journal of physiology.

[52]  H. Sluiter,et al.  Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. , 1985, The Journal of allergy and clinical immunology.